US 8552018
Substituted tricyclic compounds as protein kinase inhibitors
granted A61KA61K31/519A61K45/06
Quick answer
US patent 8552018 (Substituted tricyclic compounds as protein kinase inhibitors) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arizona Board of Regents on Behalf of the University of Arizona
- Grant date
- Tue Oct 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/519, A61K45/06, A61P, A61P35/00